Osteoporosis: Stem Cell Injections Treat Osteoporosis in Mice
Professor William Stanford is leading a research team from the University of Toronto and Ottawa Hospital that is investigating the role of stem cells in reversing bone osteoporosis in mice.
Osteoporosis is a degenerative bone disorder that largely affects menopausal women in response to lowered estrogen levels, or those undergoing cancer chemotherapy. Other risk factors of osteoporosis also include overactive parathyroid glands, low calcium intake, or gastrointestinal surgery that diminishes dietary calcium absorption.
Stanford is using mesenchymal stem cells that act as musculoskeletal progenitors when injected into the existing bone of the mice. Within six months of the experimental treatment, the study showed that healthy, functional bone completely replaced the lesioned bone. Future clinical trials are primed to use mesenchymal cells as alternative treatment for elderly patients with osteoporosis to promote bone growth and reformation.
To read more about this study, click here.